CytoDyn Inc.
CYDY
$0.25
-$0.01-2.40%
OTC PK
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.02% | -7.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.15% | -2.39% | |||
| Operating Income | -3.15% | 2.39% | |||
| Income Before Tax | -308.07% | 6.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -308.07% | 6.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -308.07% | 6.98% | |||
| EBIT | -3.15% | 2.39% | |||
| EBITDA | -3.14% | 2.39% | |||
| EPS Basic | -287.23% | 7.84% | |||
| Normalized Basic EPS | -7.14% | 6.67% | |||
| EPS Diluted | -325.53% | 38.96% | |||
| Normalized Diluted EPS | -7.14% | 6.67% | |||
| Average Basic Shares Outstanding | 0.68% | 1.07% | |||
| Average Diluted Shares Outstanding | 0.68% | 1.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||